We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock

Delisted

CDMO was delisted on the 4th of February, 2025.

67 hedge funds and large institutions have $9.53M invested in Avid Bioservices, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more call options, than puts

Call options by funds: $12K | Put options by funds: $3K

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

50% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 14

2% more funds holding

Funds holding: 6667 (+1)

30% less capital invested

Capital invested by funds: $13.7M → $9.53M (-$4.15M)

Holders
67
Holders Change
+1
Holders Change %
+1.52%
% of All Funds
1.68%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
21
Reduced
14
Closed
3
Calls
$12K
Puts
$3K
Net Calls
+$9K
Net Calls Change
-$2K

CDMO Hedge Fund Activity: Q4 2016 in Review

67 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q4 2016, worth a combined $9.53M — down 30% from $13.7M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CDMO positions and 3 closed out — a net gain of 3 holders — while 21 added to existing stakes and 14 trimmed.

The largest buyer was Squarepoint, opening a new position worth an estimated $157K. The largest seller was Vanguard Group, cutting an estimated $1.3M.

  • 67 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q4 2016, up from 66 in Q3 2016.
  • Funds reported $9.53M of Avid Bioservices, Inc. Common Stock stock for Q4 2016, down 30% quarter-over-quarter.
  • 6 funds opened new Avid Bioservices, Inc. Common Stock positions in Q4 2016 and 3 closed out, a net change of +3 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q4 2016 was Squarepoint, an estimated $157K added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q4 2016 was Vanguard Group, an estimated $1.3M sold.

Based on aggregated 13F filings for Q4 2016.